RadiosensitizerInvestigationalInvestigational
NBTXR3
Generic name: niricla
How it works
NBTXR3 is a nanoparticle that helps to increase the sensitivity of cancer cells to radiation therapy.
Cancer types
Pancreatic Cancer— All patients
Side effects
Mild
Most people tolerate this treatment well. Side effects are generally manageable and do not require stopping treatment.
Evidence from research
| Study | Cancer type | Stage | Efficacy | |
|---|---|---|---|---|
| Testing NBTXR3 with Radiation Therapy for Advanced Lung Cancer | Lung Cancer | phase-1 | — | Source → |
| NBTXR3 Combined with Radiation Therapy for Lung Cancer | Lung Cancer | phase-1 | — | Source → |
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.